Unique characteristics of AAV1, 2, and 5 viral entry, intracellular trafficking, and nuclear import define transduction efficiency in HeLa cells

Human Gene Therapy

Volumn 22, Issue 11, 2011, Pages 1433-1444

  Keiser, Nicholas W ^a   Yan, Ziying ^a   Zhang, Yulong ^a   Lei Butters, Diana C M ^a   Engelhardt, John F ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENO ASSOCIATED VIRUS; ADENO ASSOCIATED VIRUS 1; ADENO ASSOCIATED VIRUS 2; ADENO ASSOCIATED VIRUS 5; ARTICLE; CELL MEMBRANE; CELL NUCLEUS; CELL TYPE; CYTOPLASM; FLUORESCENCE; HUMAN; HUMAN CELL; MIXED INFECTION; NONHUMAN; NUCLEAR IMPORT; SEROTYPE; VIRION; VIRUS CAPSID; VIRUS ENTRY; VIRUS GENOME;

ACTIVE TRANSPORT, CELL NUCLEUS; CELL MEMBRANE; CELL NUCLEUS; DEPENDOVIRUS; GENETIC VECTORS; HELA CELLS; HUMANS; TRANSDUCTION, GENETIC;

ADENO-ASSOCIATED VIRUS; MIRIDAE;

EID: 81855184500     PISSN: 10430342     EISSN: 15577422     Source Type: Journal    
DOI: 10.1089/hum.2011.044     Document Type: Article

References (29)

1. Bantel-Schaal, U., Hub, B., and Kartenbeck, J. (2002). Endocytosis-of adeno-associated virus type 5 leads to accumulation of-virus particles in the Golgi compartment. J. Virol. 76, 2340-2349. (Pubitemid 34150702)
2. Bantel-Schaal, U., Braspenning-Wesch, I., and Kartenbeck, J. (2009). Adeno-associated virus type 5 exploits two different-entry pathways in human embryo fibroblasts. J. Gen. Virol. 90,-317-322.
3. Bartlett, J.S., Wilcher, R., and Samulski, R.J. (2000). Infectious-entry pathway of adeno-associated virus and adeno-associated-virus vectors. J. Virol. 74, 2777-2785. (Pubitemid 30117589)
4. Carter, B.J. (2005). Adeno-associated virus vectors in clinical-trials. Hum. Gene Ther. 16, 541-550.
5. Choi, V.W., McCarty, D.M., and Samulski, R.J. (2005). AAV-hybrid serotypes: improved vectors for gene delivery. Curr. Gene Ther. 5, 299-310. (Pubitemid 40895014)
6. Ding, W., Zhang, L., Yan, Z., and Engelhardt, J.F. (2005). Intracellular-trafficking of adeno-associated viral vectors. Gene-Ther. 12, 873-80.
7. Ding, W., Zhang, L.N., Yeaman, C., and Engelhardt, J.F. (2006). rAAV2 traffics through both the late and the recycling endosomes-in a dose-dependent fashion. Mol. Ther. 13, 671-682.
8. Duan, D., Li, Q., Kao, A.W., et al. (1999). Dynamin is required for-recombinant adeno-associated virus type 2 infection. J. Virol. 73, 10371-10376.
9. Duan, D., Yue, Y., Yan, Z., Yang, J., et al. (2000). Endosomal-processing limits gene transfer to polarized airway epithelia-by adeno-associated virus. J. Clin. Invest. 105, 1573-1587. (Pubitemid 30390308)
10. Gao, G., Vandenberghe, L.H., and Wilson, J.M. (2005). New recombinant-serotypes of AAV vectors. Curr. Gene Ther. 5, 285-297.
11. Girod, A., Wobus, C.E., Zadori, Z., et al. (2002). The VP1 capsid-protein of adeno-associated virus type 2 is carrying a phospholipase-A2 domain required for virus infectivity. J. Gen. Virol. 83, 973-978. (Pubitemid 34477268)
12. Grieger, J.C., Johnson, J.S., Gurda-Whitaker, B., et al. (2007). Surface-exposed adeno-associated virus Vp1-Nls capsid-fusion protein rescues infectivity of noninfectious wild-type-Vp2/Vp3 and Vp3-only capsids but not that of fivefold pore-mutant virions. J. Virol. 81, 7833-7843. (Pubitemid 47101469)
13. Hansen, J., Qing, K., Kwon, H.J., et al. (2000). Impaired intracellular-trafficking of adeno-associated virus type 2 vectors-limits efficient transduction of murine fibroblasts. J. Virol. 74,-992-996. (Pubitemid 30036236)
14. Johnson, J.S., and Samulski, R.J. (2009). Enhancement of adenoassociated-virus infection by mobilizing capsids into and out-of the nucleolus. J. Virol. 83, 2632-2644.
15. Kronenberg, S., Bottcher, B., Von Der Lieth, C.W., et al. (2005). A-conformational change in the adeno-associated virus type 2-capsid leads to the exposure of hidden VP1 N termini. J. Virol. 79, 5296-5303. (Pubitemid 40548198)
16. Lux, K., Goerlitz, N., Schlemminger, S., et al. (2005). Green-fluorescent protein-tagged adeno-associated virus particles-allow the study of cytosolic and nuclear trafficking. J. Virol. 79, 11776-11787. (Pubitemid 41279296)
17. Mani, B., Baltzer, C., Valle, N., et al. (2006). Low pH-dependent- endosomal processing of the incoming parvovirus minute-virus of mice virion leads to externalization of the VP1-N-terminal sequence (N-VP1), N-VP2 cleavage, and uncoating-of the full-length genome. J. Virol. 80, 1015-1024. (Pubitemid 43062912)
18. Pajusola, K., Gruchala, M., Joch, H., et al. (2002). Cell-typespecific- characteristics modulate the transduction efficiency of-adeno-associated virus type 2 and restrain infection of endothelial-cells. J. Virol. 76, 11530-11540. (Pubitemid 35231309)
19. Sanlioglu, S., Benson, P.K., Yang, J., et al. (2000). Endocytosis and-nuclear trafficking of adeno-associated virus type 2 are controlled-by rac1 and phosphatidylinositol-3 kinase activation. J. Virol. 74, 9184-9196.
20. Seisenberger, G., Ried, M.U., Endress, T., et al. (2001). Real-time-single-molecule imaging of the infection pathway of an adenoassociated-virus. Science 294, 1929-1932. (Pubitemid 33101590)
21. Sipo, I., Fechner, H., Pinkert, S., et al. (2007). Differential internalization-and nuclear uncoating of self-complementary-adeno-associated virus pseudotype vectors as determinants of-cardiac cell transduction. Gene Ther. 14, 1319-1329. (Pubitemid 47370845)
22. Thomas, C.E., Storm, T.A., Huang, Z., and Kay, M.A. (2004). Rapid uncoating of vector genomes is the key to efficient liver-transduction with pseudotyped adeno-associated virus vectors. J. Virol. 78, 3110-3122. (Pubitemid 38314369)
23. Vandenberghe, L.H., Wilson, J.M., and Gao, G. (2009). Tailoring-the AAV vector capsid for gene therapy. Gene Ther. 16, 311-319.
24. Wu, Z., Asokan, A., and Samulski, R.J. (2006). Adeno-associated-virus serotypes: vector toolkit for human gene therapy. Mol. Ther. 14, 316-327. (Pubitemid 44184972)
25. Xiao, W., Warrington, K.H., Jr., Hearing, P., et al. (2002). Adenovirus-facilitated nuclear translocation of adenoassociated-virus type 2. J. Virol. 76, 11505-11517. (Pubitemid 35231307)
26. Yan, Z., Zak, R., Luxton, G.W., et al. (2002). Ubiquitination of-both adeno-associated virus type 2 and 5 capsid proteins-affects the transduction efficiency of recombinant vectors. J. Virol. 76, 2043-2053. (Pubitemid 34150672)
27. Yan, Z., Zak, R., Zhang, Y., et al. (2004). Distinct classes of-proteasome-modulating agents cooperatively augment recombinant-adeno- associated virus type 2 and type 5-mediated-transduction from the apical surfaces of human airway epithelia. J. Virol. 78, 2863-2874. (Pubitemid 38314344)
28. Yan, Z., Lei-Butters, D.C., Liu, X., et al. (2006). Unique biologic-properties of recombinant AAV1 transduction in-polarized human airway epithelia. J. Biol. Chem. 281, 29684-29692. (Pubitemid 44536977)
29. Zhong, L., Li, W., Yang, Z., et al. (2004). Impaired nuclear-transport and uncoating limit recombinant adeno-associated-virus 2 vector-mediated transduction of primary murine hematopoietic-cells. Hum. Gene Ther. 15, 1207-1218. (Pubitemid 40052433)